Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Duke Energy
DUK
|
+$172M |
| 2 |
Chevron
CVX
|
+$99.4M |
| 3 |
Apple
AAPL
|
+$91.7M |
| 4 |
Evergy
EVRG
|
+$89M |
| 5 |
Consolidated Edison
ED
|
+$86.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$412M |
| 2 |
Mondelez International
MDLZ
|
+$131M |
| 3 |
Johnson & Johnson
JNJ
|
+$107M |
| 4 |
NiSource
NI
|
+$88.5M |
| 5 |
PPL
PPL Corp
PPL
|
+$86.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.81% |
| 2 | Technology | 9.77% |
| 3 | Healthcare | 7.98% |
| 4 | Utilities | 7.37% |
| 5 | Real Estate | 5.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Teradyne
TER
$58.7B
| – | – |
-31,963
| Closed | -$4.28M |
|
2052
Terex
TEX
$7.6B
| – | – |
-4,445
| Closed | -$235K |
|
2053
Triple Flag Precious Metals
TFPM
$6.96B
| – | – |
-30,012
| Closed | -$486K |
|
2054
TG Therapeutics
TGTX
$8.31B
| – | – |
-278,302
| Closed | -$6.51M |
|
2055
Tiptree Inc
TIPT
$675M
| – | – |
-17,360
| Closed | -$340K |
|
2056
TJX Companies
TJX
$155B
| – | – |
-162,818
| Closed | -$19.1M |
|
2057
Telos
TLS
$336M
| – | – |
-180,341
| Closed | -$647K |
|
2058
Transmedics
TMDX
$3.29B
| – | – |
-21,405
| Closed | -$3.36M |
|
|
TMHC
2059
DELISTED
Taylor Morrison
TMHC
| – | – |
-113,288
| Closed | -$7.96M |
|
2060
T-Mobile US
TMUS
$196B
| – | – |
-102,398
| Closed | -$21.1M |
|
2061
TriNet
TNET
$3.24B
| – | – |
-54,914
| Closed | -$5.33M |
|
2062
Towne Bank
TOWN
$3.49B
| – | – |
-102,349
| Closed | -$3.38M |
|
2063
Trex
TREX
$4.77B
| – | – |
-100,449
| Closed | -$6.69M |
|
2064
TORM
TRMD
$3.26B
| – | – |
-40,866
| Closed | -$1.37M |
|
2065
Trinity Industries
TRN
$2.37B
| – | – |
-95,551
| Closed | -$3.33M |
|
2066
T. Rowe Price
TROW
$23.8B
| – | – |
-9,993
| Closed | -$1.09M |
|
2067
TC Energy
TRP
$64.6B
| – | – |
-46,314
| Closed | -$2.2M |
|
|
TRST
2068
Trustco Bank Corp NY
TRST
$968M
| – | – |
-11,887
| Closed | -$393K |
|
|
TSBX
2069
DELISTED
Turnstone Biologics
TSBX
| – | – |
-454,026
| Closed | -$253K |
|
2070
Taysha Gene Therapies
TSHA
$1.98B
| – | – |
-68,264
| Closed | -$137K |
|
2071
Tyson Foods
TSN
$20.6B
| – | – |
-141,809
| Closed | -$8.45M |
|
2072
TTEC Holdings
TTEC
$67.5M
| – | – |
-16,724
| Closed | -$98K |
|
2073
TETRA Technologies
TTI
$1.06B
| – | – |
-105,056
| Closed | -$326K |
|
2074
TTM Technologies
TTMI
$11.6B
| – | – |
-153,195
| Closed | -$2.8M |
|
2075
Telus
TU
$15.6B
| – | – |
-55,314
| Closed | -$928K |
|
Similar funds
Michael Gelband's Q4 2024 Portfolio in Review
As of Q4 2024, Michael Gelband held 2,201 positions worth $14.6B, down 11% from $16.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Michael Gelband withdrew a net $1.86B in Q4 2024, closing 764 positions and reducing 361 holdings. Its most notable exit was Mondelez International, an estimated $131M position sold in full.
By sector, the portfolio is most concentrated in Financials at 9.8% of assets, up from 4.6% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Michael Gelband opened a new position in Duke Energy worth $164M.
- Michael Gelband's largest Q4 2024 buy was Duke Energy: 1,520,504 shares worth $164M.
- Michael Gelband added most to Chevron in Q4 2024, an estimated $99.4M increase.
- Michael Gelband's biggest Q4 2024 reduction was Microsoft, cutting an estimated $412M.
- Michael Gelband fully exited Mondelez International in Q4 2024, selling an estimated $131M.
- Michael Gelband's ten largest holdings make up 34% of its $14.6B portfolio in Q4 2024.
- Michael Gelband opened 633 new positions and closed 764 in Q4 2024.
- Michael Gelband's portfolio value fell 11% quarter-over-quarter to $14.6B.
Based on ExodusPoint Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.